| |
 John
Brooks, Ph.d.
Associate Professor
S515 PHAR
Iowa City, IA 52242-1112
319-335-8763 Office
319-353-5646 Fax
S553 PHAR Laboratory
E-mail: john-brooks@uiowa.edu
| EDUCATION |
|
Doctor of Philosophy. Economics, University
of Michigan, 1987-1993. |
|
Master of Arts, Economics, University of
North Carolina-Greensboro, 1982-1984. |
|
Bachelor of Arts, Economics, Michigan State
University, 1978-1982. |
| Professional
Experience |
|
Associate Professor - University of Iowa,
Iowa City, IA, 2002-present. |
|
Assistant Professor - University of Iowa,
Iowa City, IA, 1996-2002. |
|
Service Fellow - Agency for Health Care
Policy & Research, Rockville, MD, 1993-1996. |
|
Teaching Assistant - University of Michigan,
Ann Arbor, MI, 1989-1990. |
|
Economic Researcher - Vector Research,
Inc., Ann Arbor, MI , 1987-1993. |
|
Consultant - Data Resources, Inc., Washington,
DC, 1985-1987. |
|
Research Economist - Battelle Pacific Northwest
Laboratories, Richland, WA, 1984 -1985. |
|
Instructor - Elon College, Burlington,
NC, 1984. |
|
Teaching Assistant - University of North
Carolina-Greensboro, Greensboro, NC, 1983. |
|
Research Assistant - University of North
Carolina-Greensboro, Greensboro, NC, 1982-1983. |
| Honors
and Awards |
|
High Impact Factor Poster Presenation, International
Society for Pharmacoeconomics and Outcomes Research Meetings,
Philadelphia, PA , 2006. |
|
Teacher of the Year (P3 Class), University of Iowa
College of Pharmacy, 2005. |
|
Best Contributed Podium Presentation, International
Society for Pharmacoeconomicsand Outcomes Research Meetings,
Crystal City, VA, 1999. |
|
Faculty Development Award in Pharmacoeconomics,
Pharmaceutical Research and Manufacturers of America Foundation, 1997-1998. |
|
Veterans Administration Dissertation Fellowship, 1991-1993. |
|
Outstanding Teaching Assistant, Michigan Economics Society, 1990. |
| Research
and Scholarly Interest Areas |
| |
Healthcare Treatment Effectiveness
Research
Randomized controlled trials (RCTs) for healthcare
treatments only provide definitive clinical evidence for
patients in practice whose clinical circumstances are
similar to the patients in RCTs. For many other patients,
healthcare providers often have imperfect guidance and
substantial discretion in recommending treatments. Given
this discretion, it is not surprising that enormous treatment
variation is observed and non-clinical factors such as
provider access and local area healthcare markets affect
treatment choice. This treatment variation represents
the "art" that is necessary in medicine. The
empirical challenge for researchers is to find ways to
exploit this variation and estimate the “effectiveness”
of treatments for patients that differ from the patients
in RTCs.
Effectiveness is defined as the benefits patients
can expect to receive from treatments in real world
practice. Policy-makers need estimates of effectiveness
to help them address whether interventions are over-
or underused in practice. Treatment effectiveness can
be estimated using retrospective data by exploiting
“natural experiments” that affect treatment
choice and are assumed unrelated to confounding factors.
Theoretical models of treatment choice are required
to justify these natural experiments.
Dr. Brooks is presently tackling the theoretical and
empirical issues surrounding treatment effectiveness
research in several clinical areas including breast
cancer, prostate cancer, lung cancer, non-Hodgkin’s
lymphoma, end-stage renal disease, and acute nursing
care. He is Deputy Director of the Healthcare Effectiveness
Research Center (HERCe), a center co-sponsor by the
College of Public Health and College of Pharmacy is
dedicated to the understanding the theoretical and applied
issues associated with effectiveness research in healthcare. |
| |
|
Related Publications: |
|
|
Brooks JM, McClellan M, Wong H. "The Marginal Benefits of Invasive Treatment for Acute Myocardial Infarction: Does Insurance Coverage Matter?" Inquiry. 37(1), Spring 2000, pp 75-90.
|
|
|
Xiao H., Sorofman B, Manasse H, Taylor T, Brooks JM, "Impact of Pharmacy Closures on Patient Use of Prescription Drugs", Journal of Social and Administrative Pharmacy, 17, 2000, pp 25-33. |
|
|
Brooks JM, Chrischilles E, Scott S, Ritho J, Chen-Hardee S. "Information Gained from Linking SEER Cancer Registry Data to State-Level Hospital Discharge Abstracts". Medical Care, 38(11), November 2000, pp 1131-1140. |
|
|
Lund BC, Perry PJ, Brooks JM, Arndt S. "Clozapine and the Development of Weight-Related Outcomes: a Claims-Based Approach". Archives of General Psychiatry 49 (1-2): 286-286 Sp. Iss. SI Suppl. S APR 15 2001. |
|
|
Brooks JM, Chrischilles E, Scott S, Chen-Hardee S. "Was Lumpectomy Underutilized for Early Stage Breast Cancer? B Instrumental Variables Evidence for Stage II Patients from Iowa", Health Services Research, 38(6) Part 1, December 2003, pp 1385-1402. |
|
|
Davila JA, Brooks JM, Pendergast JF, Chrischilles EA, “The Effect of Physician Characteristics and their Practice Environment on Surgical Referral Patterns for Early-Stage Breast Cancer”, American Journal of Medical Quality, 19(6) November-December 2004, pp 266-273. |
|
|
Chrischilles EA, Klepser DG, Brooks JM, Voelker MD, Chen-Hardee SS, Scott SD, Link BK, Delgado DJ. "Effect of Clinical Characteristics on Neutropenia-Related Inpatient Costs Among Newly Diagnosed Non-Hodgkin's Lymphoma Cases During First-Course Chemotherapy", Pharmacotherapy, 25 (5), May 2005, pp 668-675. |
|
|
Brooks JM, Klepser DG, Urmie JM, Farris KB, Doucette WR, "Effect of Local Competition on the Willingness of Community Pharmacies to Supply Medication Therapy Management Services".Journal of Health and Human Services Administration, 30(1), Summer 2007: 4-27. |
|
|
Park TR, Brooks JM, Chrischilles EA, Bergus G. "Estimating the Effectiveness of a Behavioral Intervention When Treatment Benefits are Heterogeneous: Antibiotics and Otitis Media." Forthcoming Value in Health, published online Value in Health (OnlineEarly Articles).
doi:10.1111/j.1524-4733.2007.00234.x |
|
|
Brooks JM, Chrischilles EA. "Heterogeneity and the Interpretation of Treatment Effect Estimates from Risk-Adjustment and Instrumental Variable Methods” forthcoming in Medical Care, 45(10 supplement), October 2007. |
|
|
Brooks JM, Titler MG, Herr K, Ardery G, Xie X. "The Effect of Evidence-Based Acute Pain Management Practices on Inpatient Resource Use: Instrumental Variable Results from a Behavioral Intervention" submitted to Health Services Research. |
| |
Bargaining in Healthcare |
|
The prices of healthcare services have
been shown to affect both the demand for services and
their supply. Historically, economic models describing
how healthcare service prices are determined have assumed
that healthcare providers set prices based on their practice
goals and the demand for their services in a given market.
Given the changes in the healthcare system over the past
decade, though, these models appear inadequate to describe
pricing behavior in healthcare. In the face of escalating
costs, insurers have recognized the bargaining power they
have through their large beneficiary pools and have begun
bargaining with providers over price. In response to these
changes, researchers in PSE have initiated a program of
research to model and describe pricing in healthcare as
a bargaining process between providers and insurers. Our
seminal research in this area was said to “represent
a significant advance over other work by writing down
a carefully specified theoretical model of bargaining”
by Martin Gaynor and William Vogt in the Handbook of Health
Economics (North-Holland 2000). Our empirical research
focuses on application of this bargaining model to understand
the reasons for variation in bargaining power for different
combinations of providers, insurers, and market circumstances. |
| |
|
Related Publications: |
|
|
Brooks JM, Dor A, Wong H. “The
Hospital-Insurer Bargaining Process: An Empirical Investigation
of Appendectomy Pricing” Journal of Health Economics,
16(4), August 1997, 417-434. |
|
|
Brooks JM, Dor A, Wong H. "The Impact
of Physician Payments on Hospital-Insurer Bargaining in
the US" in Governments and Health Systems, D. Chinitz,
M. Cohen (eds), J. Wiley and Sons, 1998. |
|
|
Brooks JM, Doucette W, Sorofman B. “Factors
Affecting Bargaining Outcomes Between Pharmacists and
Insurers”, Health Services Research, 34(1), April
1999, Part II, 439-451. |
|
|
Doucette W, Brooks JM, Sorofman B, Hetrick,
A. “Bargaining Between Community Pharmacies and
Third Party Payers: Influences on Bargaining Outcomes”.
Journal of Managed Care Pharmacy. 7(1), January/February
2001, pp 43-49. |
|
|
Brooks JM, Doucette W, Sorofman BS. “Third
Party Bargaining and Contract Terms: The Link Over Time”.
Journal of the American Pharmaceutical Association. 42(3),
May/June 2002. pp 420-27. |
|
|
| |
|
|
| |
|
|
|
